Senior Director, Investor Relations and Corporate Communications
Ironwood Pharmaceuticals
This listing was originally posted on Ironwood Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Drug products linked to this role
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/mo
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
The Senior Director of Investor Relations and Corporate Communications will develop and execute the company’s corporate communications strategy, with a strong focus on external communications, investor relations, and internal communications. This position will be responsible for developing and delivering key messages across various channels, supporting the creation of content for investor relations and corporate presentations, and ensuring alignment across the organization. The Senior Director will play a pivotal role in maintaining the company’s public narrative, ensuring the company’s website is current, and proactively managing corporate messaging with internal and external stakeholders.
This person will play a leadership role in developing and executing an effective investor relations program and engaging with the investment community, serving as a key company contact. This person will also act as a trusted internal adviser to the executive team and the Board, sharing perspectives and feedback on investor feedback and sentiment.
This role will report to the Chief Financial Officer.
Key Responsibilities
Investor Relations:
Corporate Communications:
Qualifications
Ironwood Pharmaceuticals is an equal opportunity employer welcoming diversity in our workforce.
Ironwood currently anticipates that the initial base salary for this position could range from between $246,000 to $286,650. The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience. Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.
#LI-Hybrid
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Ironwood Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Small Molecules
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access all 4 linked drug products and competitive data and other premium pharma intelligence.
Upgrade to Pro — $25/mo